Purchase Order 75D30119P05080
Award Date 8/17/19
Potential Completion Date 8/16/22
Potential Value $167K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- This contract is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and software. The $29,770 contract provides one year of support and maintenance services for Illumina's BaseSpace Clarity software, a laboratory information management system (LIMS) used for genomic research. The...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for annual maintenance, repair, and support services for the CDC's Genomic Sequencing Laboratory's Illumina NovaSeq and MiSeq instruments. The $144,910.12 contract will provide full coverage of parts, labor, travel, reagent replacement, remote technical support, and on-site response within 2 business days, as...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $144,302.41 contract provides supplies - chemicals to support the agency's research and diagnostics needs. This award does not have a set-aside designation. Illumina has previously been awarded prime federal contracts by agencies such as NIH, USDA,...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $223,532.40, is for the maintenance and services of Illumina sequencing instruments. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $13,907.30 to Illumina, Inc. for the maintenance of laboratory equipment. The contract has a period of performance through July 20, 2024 and does not have a socioeconomic set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and services to support research and...
- Illumina, Inc. was awarded a $11,922.64 purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh for unspecified goods or services to be delivered to San Diego, California. The award was made on a firm fixed price basis with no set-aside designation. As a manufacturer and provider of sequencing and array-based solutions, Illumina likely will supply various sequencing systems, reagents, consumables, or related bioinformatics products to...
- This firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The contract, valued at $16,253.28, is for equipment maintenance services. Illumina has previously received prime and sub-awards from federal agencies like the National Institutes of Health, USDA, and Department of Veterans Affairs to provide sequencing systems, consumables, and bioinformatics support for...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...